SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)
|
3 Months Ended | 6 Months Ended | 6 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2013
|
Mar. 31, 2012
|
Mar. 31, 2013
|
Mar. 31, 2012
|
Mar. 31, 2013
Series A preferred stock [Member]
|
Mar. 31, 2012
Series A preferred stock [Member]
|
Sep. 30, 2012
Series A preferred stock [Member]
|
Mar. 31, 2013
Series C preferred stock [Member]
|
Sep. 30, 2012
Series C preferred stock [Member]
|
|
Discount to receivable face value, lower range | 2.25% | 2.25% | |||||||
Discount to the receivable face value, higher range | 6.25% | 6.25% | |||||||
FDIC Insured limits | $ 2,500,000 | $ 2,500,000 | |||||||
Research and development | 60,841 | 3,020 | 118,117 | ||||||
Warrants and options excluded for purposes of dilutive earnings per share | 1,784 | 11,163 | |||||||
common stock issued for conversion, shares | 57,400,000 | 107,400,000 | 625,476,750,000 | ||||||
Preferred stock, shares outstanding | 574,000 | 1,074,000 | 1,074,000 | 2,501,907 | 0 | ||||
Inventory reserve | 50,000 | 0 | 50,000 | 0 | |||||
Advertising costs | $ 2,188 | $ 2,809 | $ 4,728 | $ 6,240 |
X | ||||||||||
- Definition
ReceivablesFactoringDiscountRateHigherRange No definition available.
|
X | ||||||||||
- Definition
Low end of the range of discount rates for factored receivables depending upon the length of time the receivable remains outstanding. No definition available.
|
X | ||||||||||
- Definition
Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation. No definition available.
|
X | ||||||||||
- Definition
The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of the valuation account as of the balance sheet date which reduces the carrying amount of inventory to net realizable value; takes into consideration such factors as market value, excessive quantities based on expected sales, technological obsolescence, and shrinkage. May also provide for estimated product returns or price concessions pertaining to product cost. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|